Sanara MedTech Inc. (SMTI) — Financial statements
Income statement, balance sheet, and cash flow for Sanara MedTech Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 103↑19.0% | 87↑33.4% | 65↑41.8% | 46↑89.9% | 24 | |
| Cost of Revenue | 10↑25.1% | 8↑3.7% | 8↑23.5% | 6↑175.2% | 2 | |
| Gross Profit | 93↑18.3% | 79↑37.4% | 57↑44.7% | 39↑80.8% | 22 | |
| Operating Expenses | ||||||
| R&D Expenses | 5↓11.1% | 6↑38.0% | 4↑22.7% | 3↑502.7% | 0.56 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00↓100.0% | 46↑63.9% | 28 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 79↑2.8% | 77↑34.3% | 57↑24.0% | 46↑63.9% | 28 | |
| Other Expenses | 0.00↓100.0% | 3↑1225.8% | 0.23↓91.5% | 3↑344.9% | 0.60 | |
| Operating Expenses | 84↓1.7% | 85↑38.9% | 61↑18.0% | 52↑78.0% | 29 | |
| Total Costs & Expenses | 94↑0.6% | 93↑34.9% | 69↑18.6% | 58↑85.2% | 32 | |
| Operating Results | ||||||
| Operating Income | 9↑236.2% | -7↓59.3% | -4↑66.3% | -13↓69.7% | -7 | |
| Depreciation & Amortization | 3↓45.9% | 5↑34.0% | 4↑55.0% | 2↑207.2% | 0.77 | |
| EBITDA | 12↑734.7% | -2↓543.5% | -0.29↑97.5% | -12↓60.2% | -7 | |
| EBIT | 9↑234.8% | -7↓71.1% | -4↑71.6% | -14↓74.4% | -8 | |
| Interest & Other Income | ||||||
| Net Interest Income | -7↓117.5% | -3↓552.9% | -0.48 | 0.00↑100.0% | -0.00 | |
| Interest Income | 0.00↓83.3% | 0.02 | 0.00↓100.0% | 0.28 | 0.00 | |
| Interest Expense | 7↑116.1% | 3↑557.5% | 0.48↑67.1% | 0.28↑39948.7% | 0.00 | |
| Non-Operating Income | 0.00↓100.0% | 0.07↑127.1% | -0.25↓117.7% | 1↑130.2% | 0.62 | |
| Other Income / Expenses | -10↓198.4% | -3↓1322.2% | -0.22↑84.2% | -1↓129.9% | -0.62 | |
| Income Before Tax | -0.39↑96.0% | -10↓123.2% | -4↑68.1% | -14↓74.3% | -8 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00↑100.0% | -6 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -0.39↑96.0% | -10↓123.2% | -4↑45.1% | -8↓1.2% | -8 | |
| Net Income from Discontinued Operations | -37 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -38↓288.7% | -10↓124.6% | -4↑45.8% | -8↓0.2% | -8 | |
| Bottom-Line Net Income | -38↓288.7% | -10↓124.6% | -4↑45.8% | -8↓0.2% | -8 | |
| EPS (Basic) | -4.36↓282.5% | -1.14↓119.2% | -0.52↑48.0% | -1.00↑7.4% | -1.08 | |
| EPS (Diluted) | -4.36↓282.5% | -1.14↓119.2% | -0.52↑48.0% | -1.00↑7.4% | -1.08 | |
| Weighted Average Shares | 9↑1.6% | 8↑2.5% | 8↑4.7% | 8↑7.7% | 7 | |
| Weighted Average Diluted Shares | 9↑1.6% | 8↑2.5% | 8↑4.7% | 8↑7.7% | 7 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.